UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 87 filers reported holding UROGEN PHARMA LTD in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $539,385 | +38.1% | 38,500 | +2.0% | 0.14% | +51.0% |
| Q2 2023 | $390,526 | +14.2% | 37,732 | +2.0% | 0.10% | +11.6% |
| Q1 2023 | $341,880 | +4.2% | 37,000 | 0.0% | 0.09% | -7.5% |
| Q4 2022 | $328,190 | +6.6% | 37,000 | 0.0% | 0.09% | +12.0% |
| Q3 2022 | $308,000 | +1.7% | 37,000 | 0.0% | 0.08% | -10.8% |
| Q2 2022 | $303,000 | -8.5% | 37,000 | -2.6% | 0.09% | +22.4% |
| Q1 2022 | $331,000 | -67.5% | 38,000 | -48.6% | 0.08% | -64.2% |
| Q4 2021 | $1,019,000 | +63.8% | 74,000 | +100.0% | 0.21% | +47.2% |
| Q3 2021 | $622,000 | +10.1% | 37,000 | 0.0% | 0.14% | +24.1% |
| Q2 2021 | $565,000 | -21.6% | 37,000 | 0.0% | 0.12% | -12.1% |
| Q1 2021 | $721,000 | +8.1% | 37,000 | 0.0% | 0.13% | 0.0% |
| Q4 2020 | $667,000 | -6.6% | 37,000 | 0.0% | 0.13% | -39.4% |
| Q3 2020 | $714,000 | -26.1% | 37,000 | 0.0% | 0.22% | -29.2% |
| Q2 2020 | $966,000 | +46.4% | 37,000 | 0.0% | 0.31% | +27.3% |
| Q1 2020 | $660,000 | +0.5% | 37,000 | +87.9% | 0.24% | +41.5% |
| Q4 2019 | $657,000 | +40.1% | 19,692 | +11.3% | 0.17% | +6.9% |
| Q3 2019 | $469,000 | -26.3% | 17,692 | 0.0% | 0.16% | -14.9% |
| Q2 2019 | $636,000 | +72.4% | 17,692 | +76.9% | 0.19% | +45.7% |
| Q1 2019 | $369,000 | -61.4% | 10,000 | -48.0% | 0.13% | -66.5% |
| Q2 2018 | $957,000 | +0.1% | 19,230 | 0.0% | 0.38% | +11.0% |
| Q1 2018 | $956,000 | -35.7% | 19,230 | -50.0% | 0.35% | -26.9% |
| Q4 2017 | $1,486,000 | +22.6% | 38,461 | 0.0% | 0.48% | +19.6% |
| Q3 2017 | $1,212,000 | +74.4% | 38,461 | 0.0% | 0.40% | +69.7% |
| Q2 2017 | $695,000 | – | 38,461 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |